{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 36,
        "end": 48
      }
    },
    {
      "id": "T2",
      "obj": "Disease",
      "span": {
        "begin": 67,
        "end": 112
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 67,
        "end": 71
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 20,
        "end": 48
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 20,
        "end": 31
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 121,
        "end": 134
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "17516068_1",
  "text": "A phase II study of trastuzumab and capecitabine for patients with HER2 -overexpressing metastatic breast cancer : Japan Breast Cancer Research Network ( JBCRN ) 00 Trial ."
}
